Matthew Gilbert, NP
Nurse Practitioner · Virginia Beach, VANPI 1114442910
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (40.3%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 69.5% of it on its own, with 14 other manufacturers making up the rest. 2025 is the largest year on record at $5,031, 3.0 times the $1,662 reported in 2021. Among nurse practitioner clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $71.32 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$7K
- Teleflex LLC$1K
- Coloplast$517
- Clarus Therapeutics Inc.$212
- Bayer$158
- Sumitomo Pharma America, Inc.$148
- plus $494 from 9 others
What the payments were for
- Speaking & faculty fees$3,84840%
- Travel & lodging$2,36025%
- Food & beverage$3,34835%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 40 | $6,645 |
| Teleflex LLC | 8 | $1,382 |
| Coloplast | 52 | $517 |
| Clarus Therapeutics Inc. | 10 | $212 |
| Bayer | 4 | $158 |
| Sumitomo Pharma America, Inc. | 8 | $148 |
| Endo Pharmaceuticals Inc. | 2 | $129 |
| SRS Medical Systems, Inc. | 1 | $110 |
| AbbVie | 1 | $88 |
| Endo USA, Inc. | 2 | $45 |
| Antares Pharma, Inc. | 2 | $32 |
| KARL Storz Endoscopy-america | 1 | $28 |
| Vertex | 1 | $23 |
| Johnson & Johnson | 1 | $21 |
| Pfizer | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AMS 700 CXR RTE KIT$2,852
- AdVance XP$1,934
- UroLift System$1,168
- AMS 700$514
- JATENZO$396
- GENERAL ERECTILE DYSFUNCTION$116
- XIAFLEX$110
- CT3000 Pro Base Unit$110
- UroCuff-DC Disposable, Single$110
How this compares
$9,556 in reported general payments places this provider in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 83 | $80,633 |
| GemtesaVibegron | 15 | $22,081 |
| Testosterone | 70 | $17,840 |
| Tadalafil | 20 | $11,070 |
| Testosterone Cypionate | 190 | $10,575 |
| Tamsulosin Hcl | 478 | $6,937 |
| Finasteride | 226 | $2,964 |
| Solifenacin Succinate | 38 | $1,895 |
| Silodosin | 24 | $1,704 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 44 | $732 |
| Oxybutynin Chloride ErOxybutynin Chloride | 29 | $698 |
| Dutasteride | 22 | $692 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 29 | $389 |
| CiclopiroxCiclopirox Olamine | 14 | $173 |
| Doxycycline Hyclate | 15 | $160 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sumitomo Pharma America, Inc.Gemtesa | $148 | $22,08115 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,166 nurse practitioner providers in Virginia.
Other nurse practitioner in Virginia Beach
- Kristin AustriaVirginia Beach$26K
- Kimberly ClovisVirginia Beach$14K
- Lisa WalkerVirginia Beach$11K
- Barbara McCrayVirginia Beach$10K
- Colette BrooksVirginia Beach$9K
- Samantha FoxGate City$207K
- Mikel GrayCharlottesville$174K
- Kevin BrigleRichmond$166K
- Denese GomesRichmond$126K
- Ashley CarmenAlexandria$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.